InsiderTrades.com logo

CING Insider Trading

Insider Ownership Percentage: 5.30%
Insider Buying (Last 12 Months): $656,964.00
Insider Selling (Last 12 Months): $0.00

Cingulate Insider Trading History Chart

This chart shows the insider buying and selling history at Cingulate by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Cingulate Share Price & Price History

Current Price: $4.83
Price Change: ▼ Price Decrease of -0.23 (-4.55%)
As of 09/25/2026 04:00 PM ET

This chart shows the closing price history over time for CING up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Cingulate Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/13/2026Thomas Jeffrey HargrovesDirectorBuy97,276$5.04$490,271.0497,468View SEC Filing Icon  
2/6/2026Jennifer L. CallahanCFOBuy4,864$5.04$24,514.565,059View SEC Filing Icon  
2/6/2026Matthew BramsEVPBuy1,946$5.04$9,807.844,656View SEC Filing Icon  
2/6/2026Peter J. WerthDirectorBuy19,455$5.04$98,053.20117,449View SEC Filing Icon  
2/6/2026Shane J. SchafferCEOBuy6,809$5.04$34,317.3610,175View SEC Filing Icon  
8/15/2024Laurie MyersCOOSell202$4.17$842.34View SEC Filing Icon  
3/15/2024Jennifer L. CallahanCFOBuy55$27.10$1,490.502,333View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Cingulate (NASDAQ:CING)

41.31% of Cingulate stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at CING by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Cingulate Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/7/2026BlackRock Inc.53,130$0.29M0.0%N/A0.394%Search for SEC Filing on Google Icon
5/14/2026Renaissance Technologies LLC31,888$0.20M0.0%N/A0.260%Search for SEC Filing on Google Icon
5/4/2026Chicago Partners Investment Group LLC18,750$0.12M0.0%N/A0.153%Search for SEC Filing on Google Icon
4/30/2026Kestra Advisory Services LLC140,000$0.87M0.0%+14.8%1.143%Search for SEC Filing on Google Icon
2/18/2026XTX Topco Ltd20,742$90K0.0%N/A0.278%Search for SEC Filing on Google Icon
2/18/2026Quadrature Capital Ltd15,182$66K0.0%N/A0.204%Search for SEC Filing on Google Icon
2/13/2026Kestra Advisory Services LLC122,000$0.53M0.0%+29.8%1.638%Search for SEC Filing on Google Icon
2/12/2026DRW Securities LLC58,672$0.26M0.0%N/A0.788%Search for SEC Filing on Google Icon
2/11/2026LPL Financial LLC10,600$46K0.0%-47.7%0.142%Search for SEC Filing on Google Icon
2/9/2026Geode Capital Management LLC61,035$0.27M0.0%+43.9%0.819%Search for SEC Filing on Google Icon
2/6/2026Quantum Private Wealth LLC10,000$43K0.0%-58.3%0.134%Search for SEC Filing on Google Icon
2/5/2026Soltis Investment Advisors LLC10,000$43K0.0%N/A0.134%Search for SEC Filing on Google Icon
11/10/2025Quantum Private Wealth LLC24,000$94K0.0%+140.0%0.444%Search for SEC Filing on Google Icon
8/15/2025Bank of America Corp DE7,501$31K0.0%+283.1%0.143%Search for SEC Filing on Google Icon
8/12/2025XTX Topco Ltd10,943$45K0.0%N/A0.208%Search for SEC Filing on Google Icon
2/12/2025Geode Capital Management LLC27,323$0.14M0.0%N/A0.851%Search for SEC Filing on Google Icon
2/10/2025Commonwealth Equity Services LLC43,022$0.21M0.0%+281.5%1.340%Search for SEC Filing on Google Icon
1/21/2025AlphaMark Advisors LLC5,010$25K0.0%+50,000.0%0.156%Search for SEC Filing on Google Icon
11/15/2024Jane Street Group LLC21,031$0.11M0.0%N/A0.655%Search for SEC Filing on Google Icon
8/15/2024Armistice Capital LLC490,000$0.16M0.0%N/A6.671%Search for SEC Filing on Google Icon
11/15/2023Armistice Capital LLC754,792$0.54M0.0%N/A4.820%Search for SEC Filing on Google Icon
10/23/2023Commonwealth Equity Services LLC100,771$71K0.0%N/A0.643%Search for SEC Filing on Google Icon
5/5/2023Prime Capital Investment Advisors LLC48,262$48K0.0%N/A0.413%Search for SEC Filing on Google Icon
11/8/2022Eagle Asset Management Inc.107,527$0.12M0.0%+124.5%0.951%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Cingulate logo
Cingulate Inc., a biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of attention deficit/hyperactivity disorder and anxiety in the United States. The company's stimulant medications are CTx-1301 (dexmethylphenidate), which is in phase 3 clinical trial, as well as CTx-1302 (dextroamphetamine), which is in investigational new drug application development for the treatment of attention deficit/hyperactivity disorder intended for children, adolescents, and adults. It also focuses on developing CTx-2103 that is in a formulation stage for the treatment of anxiety. The company was founded in 2012 and is headquartered in Kansas City, Kansas.
Read More on Cingulate

Today's Range

Now: $4.83
Low: $4.80
High: $5.12

50 Day Range

MA: $5.09
Low: $4.52
High: $5.87

52 Week Range

Now: $4.83
Low: $3.16
High: $11.89

Volume

146,047 shs

Average Volume

91,130 shs

Market Capitalization

$70.23 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Cingulate?

Cingulate's top insider investors include:
  1. Peter J Werth (Director)
  2. Thomas Jeffrey Hargroves (Director)
  3. Shane J Schaffer (CEO)
  4. Gregg Wm Givens (Director)
  5. Jennifer L Callahan (CFO)
  6. Matthew Brams (EVP)
  7. Laurie Myers (COO)
  8. Jennifer L Callahan (Insider)
  9. Craig S Gilgallon (EVP)
  10. Curtis Medeiros (Director)
Learn More about top insider investors at Cingulate.

Who are the major institutional investors of Cingulate?

Cingulate's top institutional investors include:
  1. BlackRock Inc. — 0.39%
Learn More about top institutional investors of Cingulate stock.

Which major investors are buying Cingulate stock?

During the last quarter, CING stock was bought by institutional investors including:
  1. BlackRock Inc.
In the previous year, these company insiders have bought Cingulate stock:
  1. Peter J Werth (Director)
  2. Thomas Jeffrey Hargroves (Director)
  3. Shane J Schaffer (CEO)
  4. Jennifer L Callahan (CFO)
  5. Matthew Brams (EVP)
Learn More investors buying Cingulate stock.

Cingulate Active Insiders

Shane J Schaffer
Shane J Schaffer
Chairman and Chief Executive Officer
Jennifer L Callahan
Jennifer L Callahan
Chief Financial Officer
Peter J Werth
Peter J Werth
Director
Thomas Jeffrey Hargroves
Thomas Jeffrey Hargroves
Director
Matthew Brams
Matthew Brams
Chief Medical Officer